Proceedings of the International Scientific and Practical Conference "Sustainable development of environment after Covid-19" (SDEC 2021)

<Previous Article In Volume
Next Article In Volume>

Availability of Medicines for the Population as a Determinant of the Sustainable Development of the National Health System

Authors
Svetlana Begicheva*, Elena Kalabina
Ural State University of Economics, Yekaterinburg, Russia
*Corresponding author. Email: begichevas@mail.ru
Corresponding Author
Svetlana Begicheva
Available Online 18 January 2022.
DOI
10.2991/assehr.k.220106.003How to use a DOI?
Keywords
Medicine prices; Availability of medicines; Procurement price; Pharmacy; WHO/HAI
Abstract

The purpose of the study was to analyse the availability of medicines for the population on the example of the treatment of cardiovascular diseases in 2011 and 2019 to assess the assortment, financial and logistical availability of medicines as a determinant of the sustainable development of the national health system. A comparative and structural analysis of the availability of medicines for the treatment of diseases of the cardiovascular system was carried out according to the monitoring of the assortment and prices of vital and essential medicines in the Sverdlovsk Region for 2011 and 2019, including using the WHO’s methodology and the International Non-governmental organization “Action Program for Health and Healthcare”. The availability and prices of 274 medicines’ trade names in the hospital and outpatient segments of the Sverdlovsk region revealed and the direct costs of patients for purchasing medicines for arterial hypertension treatment in 2019 estimated. As a result, of the study, according to data from 2011 and from 2019, in general, there was a decrease in prices relative to reference prices for generic drugs for the treatment of cardiovascular diseases. To increase the effectiveness of drug provision as a determinant of the sustainable development of the national health system, additional studies of price dynamics and pharmacoeconomical analysis needed, taking into account trends in the Russian pharmaceutical market.

Copyright
© 2022 The Authors. Published by Atlantis Press SARL.
Open Access
This is an open access article under the CC BY-NC license.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the International Scientific and Practical Conference "Sustainable development of environment after Covid-19" (SDEC 2021)
Series
Advances in Social Science, Education and Humanities Research
Publication Date
18 January 2022
ISBN
10.2991/assehr.k.220106.003
ISSN
2352-5398
DOI
10.2991/assehr.k.220106.003How to use a DOI?
Copyright
© 2022 The Authors. Published by Atlantis Press SARL.
Open Access
This is an open access article under the CC BY-NC license.

Cite this article

risenwbib
TY  - CONF
AU  - Svetlana Begicheva
AU  - Elena Kalabina
PY  - 2022
DA  - 2022/01/18
TI  - Availability of Medicines for the Population as a Determinant of the Sustainable Development of the National Health System
BT  - Proceedings of the International Scientific and Practical Conference "Sustainable development of environment after Covid-19" (SDEC 2021)
PB  - Atlantis Press
SP  - 12
EP  - 17
SN  - 2352-5398
UR  - https://doi.org/10.2991/assehr.k.220106.003
DO  - 10.2991/assehr.k.220106.003
ID  - Begicheva2022
ER  -